<DOC>
	<DOCNO>NCT00965042</DOCNO>
	<brief_summary>The purpose study investigate effect ceftobiprole treatment intestinal microflora healthy volunteer .</brief_summary>
	<brief_title>Effect Ceftobiprole Human Intestinal Microflora</brief_title>
	<detailed_description>This open-label , single center study investigate effect human intestinal microflora multiple dose ceftobiprole treatment administer 8 hour interval 7 consecutive day . Careful investigation effect Ceftobiprole treatment intestinal microflora importance since alteration intestinal microflora balance may facilitate colonization pathogenic bacteria strain enable microorganism already present normal microflora develop resistance . A total 7 fecal sample collect day 2 , 4 , 7 , 10 , 14 21 determination ceftobiprole concentration fecal , intestinal microflora pattern measure susceptibility Ceftobiprole isolate bacterial strain . A total 13 plasma sample collect day 1 , 4 , 7 , 10 , 14 21 determination ceftobiprole concentration plasma . Safety evaluation include physical examination , vital sign , clinical laboratory test , electrocardiogram adverse event monitoring perform throughout study . 500 mg ceftobiprole , intravenous infusion 120 minute , every 8 hour 7 consecutive day</detailed_description>
	<mesh_term>Ceftobiprole</mesh_term>
	<mesh_term>Ceftobiprole medocaril</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Healthy volunteer body weight &gt; = 50 kg body mass index 18 30 Agree remain hospitalized trial unit 7day drug administration period leave trial unit supervision study nurse twice day one hour maximum Refrain excessive jogging strenuous exercise study Be able adhere dietary , fluid smoking restriction study Have negative pregnancy test result screen agree use adequate contraception method become pregnant donate sperm throughout study No clinically significant medical illness , abnormal finding physical examination , vital sign , laboratory test electrocardiogram , know allergy study drug , cephalosporin , betalactam antibiotic clinically significant allergy require treatment No antibiotic treatment within last 3 month No drug alcohol abuse within last 5 year No blood donation substantial loss blood 500 ml within last 3 month intention donate blood study within 1 month study completion No history smoke 10 cigarette , 2 cigar , 2 pipe tobacco 5 sniff per day within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Ceftobiprole</keyword>
	<keyword>ZEVTERA</keyword>
	<keyword>ZEFTERA</keyword>
	<keyword>Intestinal Microflora</keyword>
</DOC>